Business
– The collaboration will focus on immune checkpoint candidates discovered by Compugen for the potential treatment of cancer. – Compugen Ltd. (Nasdaq: CGEN;...
Hi, what are you looking for?
– The collaboration will focus on immune checkpoint candidates discovered by Compugen for the potential treatment of cancer. – Compugen Ltd. (Nasdaq: CGEN;...
– Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. – After years of...
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target...
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Drug development...
– Pfizer will pay $295 million for the growth hormone treatment and up to $275 million in milestone payments, and royalties. Pfizer Inc. (NYSE:...
– The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about...
A patient who had suffered a traumatic brain injury unexpectedly recovered full consciousness after the administration of midazolam, a mild depressant drug of the...
– Generic competition for Copaxone and foreign currency volatility will hit Teva’s sales. – When Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
Israel’s AposTherapy announced that it has completed a new round of financing and is launching a global initiative to offer its technology and treatment...
PolyPid, which develops an antibiotic coating for bone repair, has delayed its IPO. The company had planned to raise as much as $24 million...